Public Citizen will push the FDA to take Crestor (rosuvastatin) off the market

The consumer group, Public Citizen, will push the FDA to take Crestor (rosuvastatin) off the market.

They say it causes renal failure and rhabdomyolysis.

Public Citizen has a track record worth noticing. They successfully went after phenylpropanolamine, Rezulin, Trovan.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote